Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells

• Main Authors: Agnieszka Korga (Author), Marta Ostrowska (Author), Aleksandra Jozefczyk (Author), Magdalena Iwan (Author), Rafal Wojcik (Author), Grazyna Zgorka (Author), Mariola Herbet (Author), Gemma Gomez Vilarrubla (Author), Jaroslaw Dudka (Author)
• Format: Book
• Published: BMC, 2019-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an increasing incidence. Despite the fact that systematic chemotherapy with a doxorubicin provides only marginal improvements in survival of the HCC patients, the doxorubicin is being used in transarteria...